{"created":"2024-10-18T00:13:28.147989+00:00","id":2000941,"links":{},"metadata":{"_buckets":{"deposit":"ad365c1b-f3a9-4695-93c7-8aa18dc3e5b6"},"_deposit":{"created_by":15,"id":"2000941","owner":"15","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"2000941"},"status":"published"},"_oai":{"id":"oai:mie-u.repo.nii.ac.jp:02000941","sets":["334:627:1728958044917"]},"author_link":[],"item_8_biblio_info_6":{"attribute_name":"bibliographic_information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2023-05-17","bibliographicIssueDateType":"Issued"}}]},"item_8_description_14":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_8_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"2000-2013年に国内31施設で診断された節外性NK/T細胞リンパ腫・鼻型 (ENKL)患者を対象とした多機関共同調査研究 (NKEA)のデータを利活用した解析を行った。韓国の研究者と共同で、中枢神経系 (CNS)再発リスク予測モデルを構築した。国内患者における新世代治療による長期予後と安全性、診断-治療間隔と予後の関係、CNS再発の詳細を明らかにして報告した。2022年から、2014-2021年に国内44施設で診断されたENKL患者を対象とした新たな国内多機関共同研究 (NKEA-Next)を実施中である。","subitem_description_language":"ja","subitem_description_type":"Abstract"},{"subitem_description":"We conducted additional analyses using the data from the multi-institutional observational study (NKEA) for patients with extranodal natural killer/T-cell lymphoma, nasal type (ENKL) diagnosed between 2000 and 2013 in 31 hospitals in Japan. In collaborating with Korean researchers, we constructed a central nervous system (CNS) relapse risk prediction mode . We clarified the long-term prognosis and safety, relationship between diagnosis-treatment interval and prognosis, and details of CNS recurrence of new-generation therapy in Japanese patients. From 2022, we are conducting a next observational study (NKEA-Next) for patients with ENKL diagnosed at 44 institutions in Japan between 2014 and 2021.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_8_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"2020年度～2022年度科学研究費補助金(基盤研究(C))研究成果報告書","subitem_description_type":"Other"}]},"item_8_description_64":{"attribute_name":"科研費番号","attribute_value_mlt":[{"subitem_description":"20K08731","subitem_description_type":"Other"}]},"item_8_publisher_30":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"三重大学"}]},"item_8_text_31":{"attribute_name":"出版者（ヨミ）","attribute_value_mlt":[{"subitem_text_value":"ミエダイガク"}]},"item_8_text_65":{"attribute_name":"item_8_text_65","attribute_value_mlt":[{"subitem_text_value":"Kaken / 科研費報告書"}]},"item_8_version_type_15":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"山口, 素子","creatorNameLang":"ja"},{"creatorName":"Yamaguchi, Motoko","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"鈴木, 律朗","creatorNameLang":"ja"},{"creatorName":"Suzuki, Ritsuro","creatorNameLang":"en"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-10-18"}],"filename":"2024RP0032.pdf","filesize":[{"value":"156 KB"}],"format":"application/pdf","url":{"label":"2024RP0032.pdf","url":"https://mie-u.repo.nii.ac.jp/record/2000941/files/2024RP0032.pdf"},"version_id":"4d4a0369-c23b-4bbe-925d-a635eaf90f17"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"NK/T細胞リンパ腫","subitem_subject_scheme":"Other"},{"subitem_subject":"新世代治療","subitem_subject_scheme":"Other"},{"subitem_subject":"RT-2/3DeVIC療法","subitem_subject_scheme":"Other"},{"subitem_subject":"多機関共同研究","subitem_subject_scheme":"Other"},{"subitem_subject":"国際情報交換","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"item_resource_type","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"国際共同によるNK/T細胞リンパ腫の病態比較と治療最適化","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"国際共同によるNK/T細胞リンパ腫の病態比較と治療最適化","subitem_title_language":"ja"},{"subitem_title":"Comparison of clinical features and treatment optimization of NK/T-cell lymphoma through international collaboration","subitem_title_language":"en"}]},"item_type_id":"8","owner":"15","path":["1728958044917"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2024-10-18"},"publish_date":"2024-10-18","publish_status":"0","recid":"2000941","relation_version_is_last":true,"title":["国際共同によるNK/T細胞リンパ腫の病態比較と治療最適化"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2024-10-18T00:23:02.983367+00:00"}